Acinar prostate mucinous adenocarcinoma
diseaseOn this page
Also known as acinar colloid prostate adenocarcinomacolloid adenocarcinoma of prostatecolloid adenocarcinoma of the prostatecolloidal adenocarcinoma of prostatecolloidal adenocarcinoma of the prostatecolloidal prostate adenocarcinomamucinous adenocarcinoma of prostatemucinous adenocarcinoma of the prostateprostate colloid adenocarcinoma
Summary
Acinar prostate mucinous adenocarcinoma (MONDO:0006067) is a disease. A subtype of prostatic acinar adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | acinar prostate mucinous adenocarcinoma |
| Mondo ID | MONDO:0006067 |
| EFO | EFO:1000065 |
| DOID | DOID:3703 |
| NCIT | C5537 |
| UMLS | C1335513 |
| MedGen | 277536 |
| GARD | 0027739 |
| Is cancer (heuristic) | no |
Also known as: acinar colloid prostate adenocarcinoma · colloid adenocarcinoma of prostate · colloid adenocarcinoma of the prostate · colloidal adenocarcinoma of prostate · colloidal adenocarcinoma of the prostate · colloidal prostate adenocarcinoma · mucinous adenocarcinoma of prostate · mucinous adenocarcinoma of the prostate · prostate colloid adenocarcinoma
Disease family
This is a subtype of prostatic acinar adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › acinar cell carcinoma › prostatic acinar adenocarcinoma › acinar prostate mucinous adenocarcinoma
Related subtypes (3): acinar prostate adenocarcinoma, signet ring variant, lymphoepithelioma-like acinar prostate adenocarcinoma, acinar prostate adenocarcinoma, foamy gland variant
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.